Clinical Immunogenetics Laboratory Associate Director

Fred Hutchinson Cancer Center is an independent nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation HIV/AIDS prevention immunotherapy and COVID-19 vaccines Fred Hutch has earned a reputation as one of the worlds leading cancer infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology infusion radiation proton therapy and related services and network affiliations with hospitals in five states. Together our fully integrated research and clinical care teams seek to discover new cures to the worlds deadliest diseases and make life beyond cancer a reality.

At Fred Hutch we value collaboration compassion determination excellence innovation integrity and respect. Our mission is directly tied to the humanity dignity and inherent value of each employee patient community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems.

With the Laboratory Director is responsible for the scientific and technical oversight of the Clinical Immunogenetics Laboratory (CIL) which is specialized in histocompatibility assessment of patient and donor candidates before hematopoietic cell transplantation (HCT) post-HCT monitoring as well as non-transplant related testing.

The Associate Director will provide expertise review and approve the design development and implementation of projects and processes within the CIL as delegated by the CIL Laboratory Director. This will include certain limited procedures and practices along with supporting standard operating procedures (SOPs) validations and qualifications.

In collaboration with CIL Laboratory Director and the management team the Associate Director will provide support for program planning quality assurance performance improvement staff development and identification of capital needs.

• Regularly and directly participate in CIL clinical service/patient care activities. Respond to and address clinical care concerns regarding safety standards and practice issues that impact patient care. Oversee supervisory and technical steps in the performance of clinical duties; resolve technical problems.
• Review crossmatch antibody HLA typing engraftment test results PT results and world book search results and sign out clinical reports as needed.
• Ensure that testing systems and methodologies developed and performed for all Histocompatibility and Immunogenetic testing methods meet applicable quality requirements under ASHI standards and CLIA/CAP guidelines.
• Work in collaboration with the Laboratory Director QA Senior Manager and lab management team to provide cross-departmental oversight and guidance for quality and safety.
• Under CIL Laboratory Directors guidance provide technical and scientific oversight of CIL including development and implementation of new assays procedures and practices validations qualifications investigations and planned and unplanned variances. Serve as an approver to controlled documents in CIL as delegated by the CIL Laboratory Director.
• Ensure standard operating procedures (SOPs) are written and consistent with the methods performed in the laboratory and are adequate to determine the reliability accuracy precision and other relevant characteristics of test methods. Ensure the establishment and maintenance of acceptable levels of analytical performance per SOP for each testing system and method. Ensure all necessary remedial actions taken are documented whenever significant deviations occur from the laboratorys established performance standards.
• Provide consultation to physicians and investigators in selecting safe donors for highly sensitized patients and monitoring post-HCT engraftment as needed.
• Stay up to date with the research and technology and continue to push scientific boundaries in the field of precision medicine.
• Provide opportunities for ongoing education and training for laboratory staff to maintain and enhance expertise in histocompatibility testing. Provide education to clinicians fellows residents and other groups as appropriate.
• Maintain current knowledge of regulations requirements and standards. Participate in the review of tracking and trending analysis and provide recommendations to ensure regulatory and accreditation compliance.

Required:

• Hold an earned doctoral degree in a chemical biological medical technology or clinical laboratory science from an accredited institution and be certified and continue to be certified by a board approved by HHS or be a Doctor of Medicine osteopathy or podiatric medicine licensed to practice medicine osteopathy or podiatry in the state or other jurisdiction in which the laboratory is located. Must meet the CLIA & ASHI education requirements for laboratory directorship.
• 4 years experience in high complexity histocompatibility testing which includes at least 2 years of experience directing or supervising high complexity histocompatibility testing and 2 years of clinical training or experience in either the specialty of histocompatibility or general immunology.
• Must have HLA laboratory director certification from American College of Histocompatibility and Immunogenetics or be able to obtain HLA laboratory director certification within 1 to 2 years.
• Substantial theoretical knowledge and practical expertise in immunology transplant immunology serology genetics engraftment monitoring new test/technology development/validation and technical troubleshooting.
• Strong leadership qualities; excellent communication and organizational skills.
• Attention to detail; excellent skills in critical thinking problem solving and ability to make independent decisions.
• Demonstrated effectiveness in accomplishing objectives in a complex organization.
• Excellent interpersonal verbal and written communication skills.
• Demonstrated ability to lead and manage change.
• Must be able to work collaboratively with the CIL team administrators and clinicians across Fred Hutch.

Preferred:

• Experience in both solid organ and hematopoietic cell transplant programs.
• Experience using HLA specific LIMS.
• Experience in executing big data analysis.

The annual base salary range for this position is from $149364.80 to $248913.60 and pay offered will be based on experience and qualifications.

This position is not eligible for H-1B sponsorship at this time.

This position may be eligible for relocation assistance.

This position may be eligible for a sign-on bonus.

Fred Hutchinson Cancer Center offers employees a comprehensive benefits package designed to enhance health well-being and financial security. Benefits include medical/vision dental flexible spending accounts life disability retirement family life support employee assistance program onsite health clinic tuition reimbursement paid vacation (12-22 days per year) paid sick leave (12-25 days per year) paid holidays (13 days per year) paid parental leave (up to 4 weeks).